« Back to Record
Citation APA

Gane, E., Moreno, C., Colombo, M., Yoshida, E. E., Nelson, D., Collins, C., Lei, Y., Kosloski, M., Mensa, F. F., Lawitz, E., Pugatch, D., Papatheodoridis, G., Bräu, N., Brown, A., Pol, S., Leroy, V., & Persico, M. (2017). Glecaprevir and pibrentasvir in patients with HCV and severe renal impairment. The New England journal of medicine, 377(15), 1448-1455. doi:10.1056/NEJMoa1704053


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/261875

Gane, E., Moreno, C., Colombo, M., Yoshida, E. E., Nelson, D., Collins, C., Lei, Y., Kosloski, M., Mensa, F. F., Lawitz, E., Pugatch, D., Papatheodoridis, G., Bräu, N., Brown, A., Pol, S., Leroy, V., & Persico, M. (2017). Glecaprevir and pibrentasvir in patients with HCV and severe renal impairment. The New England journal of medicine, 377(15), 1448-1455. doi:10.1056/NEJMoa1704053